Cervical cancer screening based on human papilloma virus-DNA testing: a scientific heritage to microbiologists or to pathologists? An on-going dilemma


https://doi.org/10.4081/mm.2016.5849
Vol. 31 No. 1 (2016)
Submitted: 26 February 2016
Accepted: 26 February 2016
Published: 31 March 2016
Papilloma virus, Pap test, cervical cancer screening
Abstract Views: 1501
PDF: 726
HTML: 850
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Among the 28 current Members of the European Union, approximately 34,000 new cases of cervical cancer occur annually, with 13,000 related deaths. In Italy, about 2900 cases of cervical cancer are diagnosed annually (crude incidence rate/100,000/year=9.4). As a direct consequence, about 1016 deaths related to cervical cancer are reported annually in Italy (crude mortality rate/100,000/year=3.3). Cervical cancer stands in the 15th rank among female cancers and is currently the 3rd most common cancer in women aged 15-44 years in Italy. [..]

Venturoli, S., & Sambri, V. (2016). Cervical cancer screening based on human papilloma virus-DNA testing: a scientific heritage to microbiologists or to pathologists? An on-going dilemma. Microbiologia Medica, 31(1). https://doi.org/10.4081/mm.2016.5849

PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.

Downloads

Download data is not yet available.

Citations

Crossref
Scopus
Google Scholar
Europe PMC